DK399288D0 - Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion - Google Patents

Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion

Info

Publication number
DK399288D0
DK399288D0 DK399288A DK399288A DK399288D0 DK 399288 D0 DK399288 D0 DK 399288D0 DK 399288 A DK399288 A DK 399288A DK 399288 A DK399288 A DK 399288A DK 399288 D0 DK399288 D0 DK 399288D0
Authority
DK
Denmark
Prior art keywords
double
immune complexes
monocyty
abnormities
strength
Prior art date
Application number
DK399288A
Other languages
English (en)
Other versions
DK399288A (da
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of DK399288D0 publication Critical patent/DK399288D0/da
Publication of DK399288A publication Critical patent/DK399288A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
DK399288A 1987-07-17 1988-07-15 Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion DK399288A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7461687A 1987-07-17 1987-07-17
US12457787A 1987-11-24 1987-11-24

Publications (2)

Publication Number Publication Date
DK399288D0 true DK399288D0 (da) 1988-07-15
DK399288A DK399288A (da) 1989-01-18

Family

ID=26755855

Family Applications (1)

Application Number Title Priority Date Filing Date
DK399288A DK399288A (da) 1987-07-17 1988-07-15 Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion

Country Status (18)

Country Link
EP (1) EP0300680B1 (da)
JP (1) JP2601520B2 (da)
KR (1) KR0131880B1 (da)
CN (1) CN1035050A (da)
AT (1) ATE142500T1 (da)
AU (2) AU1820588A (da)
CA (1) CA1326999C (da)
DE (1) DE3855527T2 (da)
DK (1) DK399288A (da)
ES (1) ES2093607T3 (da)
FI (1) FI883352A (da)
HU (1) HUT47432A (da)
IE (1) IE76914B1 (da)
IL (1) IL86862A (da)
NO (1) NO175023C (da)
NZ (1) NZ225310A (da)
OA (1) OA08890A (da)
PT (1) PT87996B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0473576A4 (en) * 1989-05-19 1993-03-10 Hem Research, Inc. Short therapeutic dsrna of defined structure
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
JP3150967B2 (ja) * 1989-10-11 2001-03-26 エイチイーエム リサーチ，インコーポレイティド 二本鎖ｒｎａによる損傷に続くショックからの保護
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
JPH07501787A (ja) * 1991-07-16 1995-02-23 ヘム・ファーマスーティカル・コーポレーション サイトカイン機能不全の緩和法および診断法
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
TW589189B (en) 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CA2487328A1 (en) 1998-03-20 1999-09-30 Benitec Australia Ltd. Sirna for control of gene expression
EP2314700A1 (en) 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
CA2369944A1 (en) 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
EP2351576A1 (en) * 2004-12-29 2011-08-03 Mannkind Corporation Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
DE112016003047B4 (de) * 2015-11-17 2022-10-27 Highlight Therapeutics, S.L. Neue pharmazeutische zusammensetzung umfassend partikel umfassend einen komplex eines doppelsträngigen polyribonukleotids und eines polyalkylenimins
CN105434341B (zh) * 2015-12-22 2018-07-10 肇庆大华农生物药品有限公司 一种兽用聚腺尿苷酸注射液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US4140761A (en) * 1977-04-11 1979-02-20 The United States Of America As Represented By The Department Of Health, Education & Welfare Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen
EP0113162B1 (en) * 1982-09-16 1989-07-19 Hem Research, Inc. Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
CA1326999C (en) 1994-02-15
ES2093607T3 (es) 1997-01-01
IL86862A (en) 1993-05-13
PT87996A (pt) 1989-06-30
HUT47432A (en) 1989-03-28
EP0300680A3 (en) 1991-06-19
KR890001580A (ko) 1989-03-27
DE3855527T2 (de) 1997-04-03
FI883352A0 (fi) 1988-07-14
IL86862A0 (en) 1988-11-30
PT87996B (pt) 1995-03-31
NO175023C (no) 1994-08-17
AU1761195A (en) 1995-06-29
EP0300680B1 (en) 1996-09-11
NO882853D0 (no) 1988-06-28
JP2601520B2 (ja) 1997-04-16
NO882853L (no) 1989-01-18
JPS6490126A (en) 1989-04-06
OA08890A (en) 1989-10-31
AU1820588A (en) 1989-01-19
EP0300680A2 (en) 1989-01-25
NO175023B (no) 1994-05-09
KR0131880B1 (ko) 1998-04-17
DK399288A (da) 1989-01-18
IE76914B1 (en) 1997-11-05
ATE142500T1 (de) 1996-09-15
DE3855527D1 (de) 1996-10-17
CN1035050A (zh) 1989-08-30
NZ225310A (en) 1991-05-28
FI883352A (fi) 1989-01-18
IE881894L (en) 1989-01-17

Similar Documents

Publication Publication Date Title
DK399288A (da) Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DE69111664D1 (de) Blutpumpe und Apparat für die extracorporale Blutzirkulation.
DK465488D0 (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
DE69130586T2 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DE69007065T2 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DK0430551T3 (da) Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser
DE69100171T2 (de) Synergistische Kombination zur ophthalmischen Verwendung.
GR3022706T3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
GR3029726T3 (en) Use of a therapeutic compound for the treatment of bronchitis
OA09766A (en) "Treatment of anxiety in benzodiazepine-withdrawn patients".
ITMI931777A0 (it) Nuovi agenti per l'ossigenazione extracorporea del sangue
ATE98127T1 (de) Verwendung von peroxidlipiden zur herstellung eines arzneimittels zur behandlung von kreislaufinsuffizienz bei lokaler applikation.
UA10335A (uk) Спосіб корекції порушеhь обміhу кальцію у хворих hа сиhдром рейтера хламідійhої етіології

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment